Journal of Radiology
91吃瓜
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91吃瓜 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
91吃瓜 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 551
Indexed In
- Index Copernicus
- Google Scholar
- Open J Gate
- Genamics JournalSeek
- ResearchBible
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- ICMJE
Useful Links
Share This Page
Treatment of glioblastoma by resveratrol nanoparticles
2nd World Congress on Radiology and Oncology
Mohsena Shoja1 and Shahryari Shookab
Semnan University of Medical Sciences, Iran
Posters & Accepted Abstracts: OMICS J Radiol
DOI:
Abstract
Glioblastoma is a malignant human cancer that confers a dismal prognosis. Temozolomide (TMZ) and ionizing radiation (IR) is applied as the standard treatment for malignant gliomas. Despite advances in the combination of conventional surgery, radiotherapy and chemotherapy, median survival is poor. Radiotherapy remains merely palliative because of the existence of glioma stem cells (GSCs), which are regarded as highly radioresistant 鈥渟eed鈥� cells. Recent studies have revealed that Res has growth inhibitory activity, and it induces apoptotic or autophagic cell death in a number of human cancer cell lines. Nowadays, nanoparticles (NPs) can be loaded with therapeutic compounds such as phytochemicals, improving their bioavailability and their targeted delivery within the GBM tumor bulk. The present results suggest that Res-loaded nanoparticles could be useful for malignant glioma therapy and they can increase the toxicity of TMZ in GBM cells mainly through the inhibition of the G2/M arrest. Keywords: Glioblastoma, Resveratrol, Nanoparticle, Cancer, Radioresistant.Biography
Mohsen Shoja graduated from the Shahid Beheshti University of Medical Sciences at Tehran. He spent 10 years working in Radiology, CT scan and MRI medical imaging centers and now he is an instructor at the Paramedical School of Semnan University of Medical Sciences with a Master degree in Radiobiology and Radiation protection.
E-mail: moh3n_sh_66@yahoo.com
